AKT pathway in neuroblastoma and its therapeutic implication. - Wikidata - wikimedia - TriplyDB

AKT pathway in neuroblastoma and its therapeutic implication.

AKT pathway in neuroblastoma and its therapeutic implication.

http://www.wikidata.org/entity/Q37159523

about

Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma.Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.Targeting cancer-initiating cells with oncolytic viruses.GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.Role of TRPM2 in cell proliferation and susceptibility to oxidative stress Sam68 is a novel marker for aggressive neuroblastoma.Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine.The lack of CD131 and the inhibition of Neuro-2a growth by carbamylated erythropoietin.B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma.Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses.Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate.Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.Evaluation of destructive effects of exposure to cisplatin during developmental stage: no profound evidence for sex differences in impaired motor and memory performance.

P2860

Q34140169-EDC0FDB2-6063-4E15-98AF-DC96B4BD54FF Q34442835-459FFD11-5AAA-4EB3-A1E0-6F1FFB609750 Q34659011-7E5D433C-C02B-4953-9985-778F7E86C0D5 Q35067906-344EB380-A9EA-465B-8172-BD079AD3F190 Q36899622-718BF9E4-792B-4B82-A95E-BA4497922BD5 Q37373177-6F271EC2-1110-4E4F-9BC3-1AC276C1524A Q38474631-B1FDD9A8-4A83-4F5D-B44F-1CDE9CD1F935 Q38912443-E2A158AA-C397-44D1-B6A6-EBFEE2DDAF0F Q39080654-6AFF6691-3DE7-48F8-B597-6A6727FB94A6 Q39147077-7A29F672-4AB7-436A-ACAC-C154A280AE50 Q41520294-A444E248-D919-4D32-9FD1-E0E8A34A0E8A Q43227672-34DCF22D-66A6-4FF5-8501-73D84D09A769 Q48002684-8D6D46DD-FE2D-4048-8B6E-CE6DC7960227

P2860

AKT pathway in neuroblastoma and its therapeutic implication.

http://www.wikidata.org/entity/Q37159523

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

AKT pathway in neuroblastoma and its therapeutic implication.

@en

AKT pathway in neuroblastoma and its therapeutic implication.

@nl

type

label

AKT pathway in neuroblastoma and its therapeutic implication.

@en

AKT pathway in neuroblastoma and its therapeutic implication.

@nl

prefLabel

AKT pathway in neuroblastoma and its therapeutic implication.

@en

AKT pathway in neuroblastoma and its therapeutic implication.

@nl

P1433

Q37159523-EB9BCEA4-B327-4F13-B5DA-99E07992C5D0

P1476

Q37159523-4D323B79-707D-42F5-AE43-2891936059EA

P2093

Q37159523-3F5EC321-B107-41CB-9C12-82ABA6D3CB01

Q37159523-9D944504-EFF8-4021-AE62-AA546E2F01B4

Q37159523-CA83A7AA-4D34-4729-9C04-5B10958E2EF2

P2860

Q37159523-025ADF15-879E-4306-8AAA-1780C5A687D0

Q37159523-04158C1D-1A89-45CF-9186-E7B997BA48D5

Q37159523-045502BD-A17F-4EA4-89F7-98CD2941B307

Q37159523-0793B152-AF0D-4F60-B80F-4353D4935C87

Q37159523-109DD193-4A15-410D-A48D-45F2B5F0D473

Q37159523-13EAED29-3C96-4029-95E0-A0A1AFA00C44

Q37159523-14F6D31A-1AAB-418C-A885-6B24E29A0805

Q37159523-174729A9-F0D6-47CC-AC0B-56BE6411C96F

Q37159523-18344D7D-6485-4807-8CC2-61514A08E7BA

Q37159523-268725E2-AE37-486A-A967-64445FFC9EEA

P304

Q37159523-6682FA68-07AA-41D1-8C8E-76569D65B04B

P31

Q37159523-D8B52D4C-A13A-412E-9ECA-E1C895753158

P356

Q37159523-A543D1E1-463A-4D56-8664-44C7EC5C3F29

P433

Q37159523-6C23F770-6022-4F29-AC18-6186B2B71362

P478

Q37159523-3C912627-2DEE-4C49-98F9-EB26D66A09C9

P577

Q37159523-96777241-D412-4970-8EA3-B6D51ABA4B9C

P698

Q37159523-F0818DAA-A67A-46C2-9AED-7A81D71F0B59

P356

14737140.8.5.757

P1433

Expert Review of Anticancer Therapy

P1476

AKT pathway in neuroblastoma and its therapeutic implication.

@en

P2093

Gilles Vassal

http://www.w3.org/2001/XMLSchema#string

Hervé Sartelet

http://www.w3.org/2001/XMLSchema#string

Luc-Laurier Oligny

http://www.w3.org/2001/XMLSchema#string

P2860

Palmitoyl protein thioesterase 1 protects against apoptosis mediated by Ras-Akt-caspase pathway in neuroblastoma cells

Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma

Protein kinase B phosphorylates AHNAK and regulates its subcellular localization

Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine

Neurotrophin signal transduction in the nervous system.

Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment

Domain-specific function of ShcC docking protein in neuroblastoma cells

Identification of midkine as a mediator for intercellular transfer of drug resistance

P304

757-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.8.5.757

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18471048

http://www.w3.org/2001/XMLSchema#string